Virginia Commonwealth University (Sanger Hall) — Richmond, Virginia

Virginia Commonwealth University (Sanger Hall) is a clinical research site located in Richmond, Virginia, United States 23298.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Virginia Commonwealth University (Sanger Hall) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myotonic Dystrophy Type 1 (DM1).

Sponsors: Vertex Pharmaceuticals Incorporated.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Virginia Commonwealth University (Sanger Hall)?

Virginia Commonwealth University (Sanger Hall) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Virginia Commonwealth University (Sanger Hall) conducted?

Virginia Commonwealth University (Sanger Hall) has 1 clinical trials on record, with 1 currently active. Their work covers Myotonic Dystrophy Type 1 (DM1).

Is Virginia Commonwealth University (Sanger Hall) accredited by Crixeo Health?

Virginia Commonwealth University (Sanger Hall) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Virginia Commonwealth University (Sanger Hall)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.